Cervical cancer is the third most common malignancy in women worldwide, and it remains a leading cause of cancer-related death for women in developing countries. Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases of cervical cancer. Cancer screening using the Pap smear can identify precancerous changes in cervical cells. Recognition of the etiologic role of HPV infection in cervical cancer has led to the recommendation of adding HPV testing to the screening regimen. However, women who have symptoms, abnormal screening test results, or a gross lesion of the cervix are best evaluated with colposcopy and biopsy. HPV vaccines are currently approved for the prevention of HPV-associated cervical dysplasia and neoplasia. Treatment of cervical cancer usually consists of surgery in early stages, and chemotherapy and/or radiotherapy in more advanced stages of the disease. This book provides a comprehensive review of cervical cancer along with its risk factors and screening, which will be of immense value for physicians and allied health professionals.